Literature DB >> 11553510

Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats.

C A Bickel1, J G Verbalis, M A Knepper, C A Ecelbarger.   

Abstract

Renal sodium retention, as a result of increased abundance of sodium transporters, may play a role in the development and/or maintenance of the increased blood pressure in obesity. To address this hypothesis, we evaluated the relative abundances of renal sodium transporters in lean and obese Zucker rats at 2 and 4 mo of age by semiquantitative immunoblotting. Mean systolic blood pressure was higher in obese rats relative to lean at 3 mo, P < 0.02. Furthermore, circulating insulin levels were 6- or 13-fold higher in obese rats compared with lean at 2 or 4 mo of age, respectively. The abundances of the alpha(1)-subunit of Na-K-ATPase, the thiazide-sensitive Na-Cl cotransporter (NCC or TSC), and the beta-subunit of the epithelial sodium channel (ENaC) were all significantly increased in the obese rats' kidneys. There were no differences for the sodium hydrogen exchanger (NHE3), the bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2 or BSC1), the type II sodium-phosphate cotransporter (NaPi-2), or the alpha-subunit of ENaC. These selective increases could possibly increase sodium retention by the kidney and therefore could play a role in obesity-related hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553510     DOI: 10.1152/ajprenal.2001.281.4.F639

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  27 in total

Review 1.  Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family.

Authors:  Steven C Hebert; David B Mount; Gerardo Gamba
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

2.  Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol.

Authors:  Lucia Mézešová; Veronika Jendruchová-Javorková; Jana Vlkovičová; Zuzana Kyselova; Jana Navarová; Stefan Bezek; Norbert Vrbjar
Journal:  Mol Cell Biochem       Date:  2012-03-22       Impact factor: 3.396

3.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

Review 4.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

Review 5.  The WNK kinase network regulating sodium, potassium, and blood pressure.

Authors:  Ewout J Hoorn; Joshua H Nelson; James A McCormick; David H Ellison
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

Review 6.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

Review 7.  Regulation of the renal Na+-Cl- cotransporter by phosphorylation and ubiquitylation.

Authors:  Gerardo Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

8.  Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption.

Authors:  Jonathan M Nizar; Blythe D Shepard; Vianna T Vo; Vivek Bhalla
Journal:  JCI Insight       Date:  2018-08-23

9.  Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis.

Authors:  M Marlina Manhiani; A Daniel Duggan; Hunter Wilson; Michael W Brands
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

10.  Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats.

Authors:  John Baynes; David B Murray
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.